If you have questions, we have answers, just ask us!

Finding the right product doesn’t have to be overwhelming or expensive. To help you, the Meenta marketplace brings together the widest array of diagnostic products and laboratory services combined with world-class scientific expertise and clinical oversight all in one place.

Genesys Diagnostics

Hereditary Cardiac Diseases Arrhythmia & Cardiomyopathy Comprehensive Panel

$750.00 per test

Helps individuals who want to detect any risk of possible arrhythmias and heart disease that makes it hard for the heart to pump by using the latest next generation sequencing because unlike any other Clinical Diagnostics marketplace Meenta offers unfettered access to validated tests.  

 

Compare
Description

Purpose: Detect risk of possible arrhythmias and heart disease that makes it hard for the heart to pump.

Benefits:

  • Reveals genetic risk in yourself and close relatives
  • Comprehensive genetic test for cardiac diseases arrhythmia & cardiomyopathy
  • Outlines hereditary mutations that can reveal increased risk to future generations
  • Analyzes cardiac genes 
  • Informs healthcare decisions and lifestyle changes
  • Sample type: Cheek swab

Technology: Next Generation Sequencing

Turnaround time: 3-4 weeks from receipt in lab

Looking at the genes inherited from parents can give insight into ways in which a person can alter lifestyle to have a richer, healthier life.  

The Center for Disease Control suggests that 1 of 500 adults may have cardiomyopathy. Cardiomyopathy is a term used to describe a collection of diverse conditions of the heart muscle.  A cardiomyopathy causes the pumping action of the heart to decrease which can produce irregular heartbeats, the backup of blood into the lungs or rest of the body, and heart failure.  It affects both genders, all ages and races, although it is more prevalent in blacks than whites and more common in males than females. Hypertrophic cardiomyopathy is thought to be the most common inherited or genetic heart disease, followed by Arrhythmogenic cardiomyopathy.1

This test offers a comprehensive analysis of the genes associated with inherited arrhythmia and cardiomyopathy. Given the clinical overlap between different arrhythmia and cardiomyopathy conditions, comprehensive testing enables a more efficient evaluation of multiple conditions based on a single indication for testing.

 

Individuals with clinical symptoms of an inherited arrhythmia or cardiomyopathy may benefit from genetic testing to establish a diagnosis, clarify risks, or inform therapeutic management. It is also becoming more well known that Covid-19 has often led to Long Term Covid and the heart is seen as one of the bigger issues, especially with underlying disease that may not yet be symptomatic. Looking at the genes inherited from parents can give insight into ways in which a person can alter lifestyle to have a richer, healthier life.  

The Center for Disease Control suggests that 1 of 500 adults may have cardiomyopathy. Cardiomyopathy is a term used to describe a collection of diverse conditions of the heart muscle.  A cardiomyopathy causes the pumping action of the heart to decrease which can produce irregular heartbeats, the backup of blood into the lungs or rest of the body, and heart failure.  It affects both genders, all ages and races, although it is more prevalent in blacks than whites and more common in males than females. Hypertrophic cardiomyopathy is thought to be the most common inherited or genetic heart disease, followed by Arrhythmogenic cardiomyopathy.(1)

(1)Center for Disease Control., December 2019. : Cardiomyopathy National Center for Chronic Disease Prevention and Health Promotion , Division for Heart Disease and Stroke PreventionAvailable here: https://www.cdc.gov/heartdisease/cardiomyopathy.htm

 

Product Details

This test includes:

BX5, TBX20, TCAP, TGFB3, TMEM43, TMPO, TNNC1, TNNI3, TNNT2, TPM1, TRDN, TRIM63, TRPM4, TTN, TTR, TXNRD2, VCL, ZBTB17ABCC9, ACTA1, ACTC1, ACTN2, AKAP9, ALMS1, ANK2, ANKRD1, BAG3, BRAF, CACNA1C, CACNA2D1, CACNB2, CALM1, CALR3, CASQ2, CAV3, CBL, CBS, COX15, CRYAB, CSRP3, CTF1, DES, DMD, DNAJC19, DOLK, DPP6, DSC2, DSG2, DSP, DTNA, EMD, EYA4, FHL1, FHL2, FKRP, FKTN, FXN, GAA, GATAD1, GJA5, GLA, GPD1L, HCN4, HFE, HRAS, HSPB8, ILK, JPH2, JUP, KCNA5, KCND3, KCNE1, KCNE2, KCNE3, KCNH2, KCNJ2, KCNJ5, KCNJ8, KCNQ1, KLF10, KRAS, LAMA2, LAMA4, LAMP2, LDB3, LMNA, LTBP2, MAP2K1, MAP2K2, MIB1, MURC, MYBPC3, MYH6, MYH7, MYL2, MYL3, MYLK2, MYO6, MYOZ2, MYPN, NEXN, NKX2-5, NPPA, NRAS, PDLIM3, PKP2, PLN, PRDM16, PRKAG2, PRKAR1A, PTPN11, RAF1, RANGRF, RBM20, RYR1, RYR2, SALL4, SCN1B, SCN2B, SCN3B, SCN4B, SCN5A, SCO2, SEPN1, SDHA, SGCB, SGCD, SGCG, SHOC2, SLC25A4, SNTA1, SOS1, TAZ, TBX3, T

How do I interpret the results?

Genetic counseling is generally recommended for any individual taking this test and their family. A medical provider can request reanalysis of the variants, and this is recommended on an annual basis. Data from this next-generation sequencing analysis can be reassessed for the presence of any new variants that may be newly linked to established genes or to newly characterized genes and/or disorders identified since the data used in this report was generated. A charge may be applied for reanalysis. Please contact support@meenta.io for more information at the time reanalysis is requested.

Sample Details

Cheek swab in viral transport media shipped at room temperature

Payment Methods
  • Credit Card
  • HSA Card
  • ACH
  • PayPal
  • PO Number

Note: These products and services are not returnable. Check your kit expiration date upon receipt. Using expired test kits is not recommended because they may provide inaccurate results.

Questions?

Call (888) 204-5303 or email support@meenta.io

More information about COVID-19 can be found on the CDC website and the Meenta blog.